Trials / Sponsors / James Murrough
James Murrough
Academic / Other · 9 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Harmine in Healthy Subjects Diabetes Mellitus | Phase 1 | 2022-09-13 |
| Completed | XEN1101 for Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2021-10-19 |
| Completed | Study to Treat Major Depressive Disorder With a New Medication Depressive Disorder, Anhedonia | Phase 2 | 2017-09-25 |
| Completed | Nuedexta in Treatment-Resistant Major Depression Major Depressive Disorder, Treatment Resistant | Phase 2 | 2013-07-01 |
| Completed | A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD) Posttraumatic Stress Disorder | Phase 1 | 2012-12-01 |
| Completed | Ketamine For Suicidal Ideation Suicidal Ideation | Phase 4 | 2012-01-01 |
| Completed | Intranasal Ketamine in Treatment-Resistant Depression Major Depressive Disorder | N/A | 2011-10-01 |
| Terminated | Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression Major Depression, Bipolar Depression | N/A | 2010-04-01 |
| Completed | Continuation Ketamine in Major Depression Major Depressive Disorder | Phase 1 | 2007-10-01 |